Company intelligence / Profile preview

Aromyx

Palo Alto, California, United States

Ownership: Private
Employees: ~14
Development stage: Other

Overview

Aromyx does not develop therapeutic drugs; it provides a receptor-based sensing and data platform that digitizes human smell and taste for applications ranging from biologic drug fermentation optimization to food, consumer products, agriculture, and diagnostics.[1][2][3][4]

Industry: Non-Drug Biotech

Partnerships

Unnamed large pharmaceutical company collaborating on biologic drug fermentation and production optimization (reported $250,000 R&D program)[1]Unnamed large agriculture company for pilot program using the sensing platform[1]Various partners across plant-based foods, disease diagnostics, fermentation, and recycled plastics applications[3]

Beyond the preview

Go deeper on Aromyx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aromyx.

Explore the full profile